Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Chaffetz, as chair of the committee on oversight and government reform, led an effort against the Centers for Disease Control and Prevention to reduce opioid prescribing by recommending that doctors first seek alternative treatments for chronic pain.
Simplified Text
Chaffetz led effort against CDC to reduce opioid prescribing recommending alternative treatments for chronic pain.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "topic": "Opioid prescribing reduction",
    "person": "Jason Chaffetz",
    "condition": "Chronic pain",
    "organization": "Centers for Disease Control and Prevention"
}
UUID
9fdb30c2-cf19-4cfd-997a-09e5fd78d36e
Vector Index
✗ No vector
Created
September 12, 2025 at 12:40 AM (16 hours ago)
Last Updated
September 12, 2025 at 12:40 AM (16 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis
https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis

Pharmaceutical industry lobbying and campaign contributions heavily influence US politics, hindering efforts to curb the opioid crisis. This influence is seen in legislation, impacting drug pricing and the DEA's ability to regulate opioid distribution.

Opioid Crisis
Pharmaceutical Industry
Lobbying
US Politics
Campaign Finance
Healthcare Policy

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP